← FDA Drug Approvals (Drugs@FDA)
WAYRILZ
NDA · New Drug Application · Sponsor: GENZYME CORP · Approved 2025-08-29
Drug application
- FDA Application #
NDA219685- Application type
- New Drug Application
- Brand name
- WAYRILZ
- Generic name
- RILZABRUTINIB
- Active ingredients
- RILZABRUTINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GENZYME CORP
- Manufacturer
- Genzyme Corporation
- First approval
- 2025-08-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown